”A strong platform for new and transformative treatments”
Sobi’s Annual Report 2016 is now available online
Click here to read about Sobi’s eventful year
Sobi has been involved in the development and manufacturing ofrecombinant protein drugssince the technology was first developed more than30 years ago.
We want to make a differenceto people with rare diseases.
By working closely with patients and their relatives we learn about their daily challenges and needs.
Swedish Orphan Biovitrum AB (publ)
SE-112 76 Stockholm, SwedenPhone: +46 8 697 20 00
© 2013 Swedish Orphan Biovitrum AB (publ) – All rights reserved
Společnost SOBI již dále nenese odpovědnost za obsah ani funkčnost internetových stránek jiných subjektů.
Přejete si opustit stránky?